This study firstly performed a long‐term survival model prediction and economic evaluation of pembrolizumab alone or with chemotherapy for advanced PD‐L1 CPS≥1 and CPS≥10 gastric cancer from the perspective of both the US and China. The gene discussed is CD274; the disease is gastric cancer.